Skip to content
Research Article Open access CC BY 4.0

The Prevalence of Tuberculosis among BCG Vaccinated Individuals at the North West Region of Cameroon

Donfack Jean Hubert, Dosi Samuel Kidia, Atemkeng Tsatedem Faustin, Wandji Kounougo Rene, Ngueguim Tsofack Florence

Asian Journal of Medicine and Health · pp. 1–11 · Published 20 Aug 2022

10.9734/ajmah/2022/v20i1130521

Abstract

Aims: This study focuses as it main objective to determine the effectiveness of early BCG vaccination in preventing tuberculosis. Study Design: It was a cross sectional descriptive study. The study population being all early BCG vaccinated individuals. Place and Duration of Study: This study was carried out from March to June 2017 at the Saint Elizabeth General Hospital Shisong, situated in Kumbo Town (Bui Division), North West region of Cameroon. Methodology: It was based on the administration of a structured questionnaire to all early BCG vaccinated individuals. Biological data were obtained from sputum collected from participants. Sputum was analyzed using Xpert MTB/RIF assay which simultaneously detects MTB-complex and rifampin resistance strain by amplifying and identifying a MTB-complex specific sequence of the rpoB gene. Results: This finding shows an overall prevalence of 13.08% on early BCG vaccinated individuals seeking medical care at the Saint Elizabeth General Hospital Shisong. The prevalence of TB in HIV positive subjects was 22.05%. The occurrence was high among HIV subjects not living on ART, 6 (33.33%) against 3 (13%) in HIV subject on ART. This study also showed that male patients 11 (15.94%) developed TB compared to female patients 3 (7.89%). The rate of infection, 9 (28.13%) occurring within the age range of > 28 - 38 associated to the development of TB with no correlation. Drinking habit was found to be associated with the development of TB with weak correlation and the occurrence of TB do not seem to be associated drinking duration. Conclusion: These results show the necessity of the application of a suitable measure to prevent TB in adults, especially those at high risk of developing the disease irrespective of early childhood BCG vaccination status.

Mycobacterium tuberculosis BCG vaccine HIV North West Region of Cameroon

References (31)

  1. 1 International Journal of Epidemiology [DOI]
  2. 2 Human Vaccines & Immunotherapeutics [DOI]
  3. 3 Prospects for Tuberculosis Elimination [DOI]
  4. 4 Association between Chronic Obstructive Pulmonary Disease and Employment by Industry and Occupation in the US Population: A Study of Data from the Third National Health and Nutrition Examination Survey [DOI]
  5. 5 Investigation of the risk factors for tuberculosis: a case–control study in three countries in West Africa [DOI]
  6. 6 Seasonal variation and prevalence of tuberculosis among health seekers in the south western Cameroon [DOI]
  7. 7 Risk factors for pulmonary tuberculosis: a clinic-based case control study in The Gambia [DOI]
  8. 8 BCG vaccine: efficacy and indications for vaccination and revaccination [DOI]
  9. 9 Risk Factors of Active Tuberculosis in People Living with HIV/AIDS in Southwest Ethiopia: A Case Control Study [DOI]
  10. 10 Determinant Factors Associated with Occurrence of Tuberculosis among Adult People Living with HIV after Antiretroviral Treatment Initiation in Addis Ababa, Ethiopia: A Case Control Study [DOI]
  11. 11 Clinical manifestations of tuberculosis in HIV‐infected patients [DOI]
  12. 12 Clinical profile of tuberculosis in patients with HIV Infection/AIDS.
  13. 13 Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic [DOI]
  14. 14 BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection [DOI]
  15. 15 Marital status and HIV prevalence among women in Nigeria: Ingredients for evidence-based programming [DOI]
  16. 16 The influence of marital status on HIV infection in an HIV hyperendemic area of rural South Africa, 2000–2017 [DOI]
  17. 17 Delaying BCG Vaccination Until 8 Weeks of Age Results in Robust BCG-Specific T-Cell Responses in HIV-Exposed Infants [DOI]
  18. 18 BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells [DOI]
  19. 19 Clinical Presentation of Tuberculosis and the Degree of Immunodeficiency in Patients with HIV Infection [DOI]
  20. 20 Incidence of tuberculosis and immunological profile of TB/HIV co-infected patients in Nigeria [DOI]
  21. 21 Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis [DOI]
  22. 22 Clinical manifestations of tuberculosis in HIV-infected patients [DOI]
  23. 23 Clinical studies on seroprevalence of rubella virus in pregnant women of Cameroon regions. [DOI]
  24. 24 Tuberculosis and its particularities in Romania and worldwide.
  25. 25 The patterns of in vitro cell-death and inflammatory cytokines induced by distinct BCG vaccine strains are differentially induced in human mononuclear cells [DOI]
  26. 26 Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection [DOI]
  27. 27 CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts [DOI]
  28. 28 Epidemiology of extra pulmonary tuberculosis in Eastern Sudan [DOI]
  29. 29 Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic Setting [DOI]
  30. 30 Clinical presentations and outcomes of TB among HIV-positive patients.
  31. 31 The characteristics of pulmonary tuberculosis amongst patients attending chest clinic, including age, sex, occupation and hemoglobin concentration in Benin City, Nigeria [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.